| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Danna B Zimmer | |
| Anne R Bresnick | |||
| David J Weber | |||
| P2860 | cites work | Selective expression of S100A11 in lung cancer and its role in regulating proliferation of adenocarcinomas cells | Q84809412 |
| Therapeutic targeting of tumor growth and angiogenesis with a novel anti-S100A4 monoclonal antibody | Q21132534 | ||
| S100A9 interaction with TLR4 promotes tumor growth | Q21134707 | ||
| Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides | Q21145828 | ||
| S100A7 and the progression of breast cancer | Q22000741 | ||
| Psoriasin (S100A7) expression and invasive breast cancer | Q22010926 | ||
| Psoriasin expression in mammary epithelial cells in vitro and in vivo | Q24292122 | ||
| A putative role for psoriasin in breast tumor progression | Q24298889 | ||
| S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways | Q24598566 | ||
| Comprehensive molecular portraits of human breast tumours | Q24630844 | ||
| Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein | Q24641894 | ||
| Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells | Q24658240 | ||
| S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast | Q24805971 | ||
| Common gene pathways and families altered by DNA methylation in breast and prostate cancers | Q27025145 | ||
| Frequent polymorphic variations but rare tumour specific mutations of the S100A2 on 1q21 in non-small cell lung cancer | Q81701022 | ||
| Plasminogen receptor S100A10 is essential for the migration of tumor-promoting macrophages into tumor sites | Q82285506 | ||
| Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer | Q82606605 | ||
| Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors | Q82657236 | ||
| Lost in migration | Q83155814 | ||
| Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene | Q83353256 | ||
| Review of S100A9 biology and its role in cancer | Q36896567 | ||
| Premetastatic soil and prevention of breast cancer brain metastasis | Q36943888 | ||
| CD166/ALCAM mediates proinflammatory effects of S100B in delayed type hypersensitivity | Q36948770 | ||
| Ceramide 1-phosphate mediates endothelial cell invasion via the annexin a2-p11 heterotetrameric protein complex | Q37000587 | ||
| Functions of S100 proteins. | Q37001259 | ||
| In vivo screening of S100B inhibitors for melanoma therapy | Q37033010 | ||
| S100B promotes glioma growth through chemoattraction of myeloid-derived macrophages | Q37051646 | ||
| A colorectal cancer classification system that associates cellular phenotype and responses to therapy | Q37175913 | ||
| Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100b-binding protein | Q37332768 | ||
| Linking folding and binding | Q37373866 | ||
| Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target | Q37389009 | ||
| Solution structure of S100A1 bound to the CapZ peptide (TRTK12). | Q37401737 | ||
| Silencing of S100A4, a metastasis-associated protein, in endothelial cells inhibits tumor angiogenesis and growth | Q37502777 | ||
| Designing and developing S100P inhibitor 5-methyl cromolyn for pancreatic cancer therapy | Q37665005 | ||
| Wnt up your mind - intervention strategies for S100A4-induced metastasis in colon cancer | Q37679562 | ||
| Transcriptional regulation and functional implication of S100P in cancer | Q37692260 | ||
| Oxidative modifications of DAMPs suppress inflammation: the case for S100A8 and S100A9. | Q37797506 | ||
| The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine | Q37881725 | ||
| Update on the epidermal differentiation complex. | Q37971574 | ||
| Molecular genetics of prostate cancer: emerging appreciation of genetic complexity | Q37972706 | ||
| From genes to drugs: targeted strategies for melanoma | Q37999967 | ||
| Application of molecular techniques in the diagnosis, prognosis and management of patients with colorectal cancer: a practical approach | Q38015538 | ||
| Joining S100 proteins and migration: for better or for worse, in sickness and in health. | Q38118075 | ||
| Inflammation and skin cancer: old pals telling new stories | Q38165688 | ||
| Functional evidence implicating S100P in prostate cancer progression | Q38291350 | ||
| Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens. | Q38313886 | ||
| S100A9 is a novel ligand of EMMPRIN that promotes melanoma metastasis | Q38320167 | ||
| Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer | Q38326104 | ||
| Glucocorticoid receptor-mediated transcriptional activation of S100P gene coding for cancer-related calcium-binding protein. | Q38333462 | ||
| Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization | Q38391163 | ||
| S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer | Q39007287 | ||
| Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties | Q39064628 | ||
| RAGE-binding S100A8/A9 promotes the migration and invasion of human breast cancer cells through actin polymerization and epithelial-mesenchymal transition | Q39068126 | ||
| Impact of S100A8/A9 expression on prostate cancer progression in vitro and in vivo | Q39079681 | ||
| S100A11 overexpression contributes to the malignant phenotype of papillary thyroid carcinoma. | Q39113324 | ||
| Comparative proteomics of glioma stem cells and differentiated tumor cells identifies S100A9 as a potential therapeutic target | Q39128660 | ||
| RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway | Q39129170 | ||
| Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion. | Q39212411 | ||
| Prostaglandin E2 stimulates S100A8 expression by activating protein kinase A and CCAAT/enhancer-binding-protein-beta in prostate cancer cells | Q39326250 | ||
| S100P, a potential novel prognostic marker in colorectal cancer | Q39354821 | ||
| Knockdown of S100A4 decreases tumorigenesis and metastasis in osteosarcoma cells by repression of matrix metalloproteinase-9. | Q39403731 | ||
| In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer | Q39464914 | ||
| Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma. | Q39584443 | ||
| The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers | Q39618327 | ||
| Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice | Q39707595 | ||
| RAGE and S100 protein transcription levels are highly variable in human melanoma tumors and cells | Q39749194 | ||
| Short hairpin RNA-mediated inhibition of S100A4 promotes apoptosis and suppresses proliferation of BGC823 gastric cancer cells in vitro and in vivo | Q39769588 | ||
| S100A8 and S100A9 are novel nuclear factor kappa B target genes during malignant progression of murine and human liver carcinogenesis. | Q39814040 | ||
| S100A8 and S100A9 overexpression is associated with poor pathological parameters in invasive ductal carcinoma of the breast | Q39974430 | ||
| Adjuvant therapy with small hairpin RNA interference prevents non-small cell lung cancer metastasis development in mice | Q40002529 | ||
| Reciprocal negative regulation between S100A7/psoriasin and beta-catenin signaling plays an important role in tumor progression of squamous cell carcinoma of oral cavity. | Q40020050 | ||
| Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling | Q40085596 | ||
| Modified expression of Mts1/S100A4 protein in C6 glioma cells or surrounding astrocytes affects migration of tumor cells in vitro and in vivo. | Q40183154 | ||
| S100A2 induces metastasis in non-small cell lung cancer | Q45398473 | ||
| Calcium-binding properties of wild-type and EF-hand mutants of S100B in the presence and absence of a peptide derived from the C-terminal negative regulatory domain of p53. | Q46480214 | ||
| Extracellular S100A4(mts1) stimulates invasive growth of mouse endothelial cells and modulates MMP-13 matrix metalloproteinase activity | Q47662103 | ||
| A soluble protein characteristic of the nervous system | Q47721048 | ||
| Expression of antisense RNA to S100A4 gene encoding an S100-related calcium-binding protein suppresses metastatic potential of high-metastatic Lewis lung carcinoma cells | Q48054885 | ||
| Inhibition of p53 transcriptional activity by the S100B calcium-binding protein | Q49236826 | ||
| S100A3 suppression inhibits in vitro and in vivo tumor growth and invasion of human castration-resistant prostate cancer cells. | Q53248783 | ||
| Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. | Q53360582 | ||
| Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model. | Q53631324 | ||
| S100P calcium-binding protein expression is associated with high-risk proliferative lesions of the breast. | Q53645627 | ||
| S100P is a metastasis-associated gene that facilitates transendothelial migration of pancreatic cancer cells. | Q54290587 | ||
| Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme | Q58048723 | ||
| Mutually antagonistic actions of S100A4 and S100A1 on normal and metastatic phenotypes | Q58377503 | ||
| A rapid separation of S100 subunits by high performance liquid chromatography: the subunit compositions of S100 proteins | Q71221320 | ||
| Effect of mts1 (S100A4) expression on the progression of human breast cancer cells | Q71574517 | ||
| Metastasis of mammary carcinomas in GRS/A hybrid mice transgenic for the mts1 gene | Q71733492 | ||
| Radiation therapy for malignant melanoma | Q71931107 | ||
| Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells | Q73010028 | ||
| A heterocomplex formed by the calcium-binding proteins MRP8 (S100A8) and MRP14 (S100A9) binds unsaturated fatty acids with high affinity | Q73182618 | ||
| Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer | Q73629119 | ||
| S100B protein in clinical diagnostics: assay specificity | Q75227914 | ||
| Urinary excretion of epidermal-type fatty acid-binding protein and S100A7 protein in patients with cutaneous melanoma | Q78595168 | ||
| Recognition of the tumor suppressor protein p53 and other protein targets by the calcium-binding protein S100B | Q79161452 | ||
| Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer | Q80471059 | ||
| Profiling early head and neck cancer | Q81348453 | ||
| Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma | Q27309626 | ||
| Structure of Ca 2+ -Bound S100A4 and Its Interaction with Peptides Derived from Nonmuscle Myosin-IIA † | Q27650317 | ||
| Divalent Metal Ion Complexes of S100B in the Absence and Presence of Pentamidine | Q27651040 | ||
| Fragmenting the S100B-p53 interaction: combined virtual/biophysical screening approaches to identify ligands | Q27658965 | ||
| Molecular level interactions of S100A13 with amlexanox: inhibitor for formation of the multiprotein complex in the nonclassical pathway of acidic fibroblast growth factor | Q27660013 | ||
| Phenothiazines inhibit S100A4 function by inducing protein oligomerization | Q27660911 | ||
| S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE) | Q28184570 | ||
| Psoriasin interacts with Jab1 and influences breast cancer progression | Q28191754 | ||
| Characterization of the metastasis-associated protein, S100A4. Roles of calcium binding and dimerization in cellular localization and interaction with myosin | Q28205156 | ||
| Effect of Mts1 on the structure and activity of nonmuscle myosin II | Q28257003 | ||
| Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis | Q28275735 | ||
| Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors | Q28283566 | ||
| Novel S100A7 (psoriasin)/S100A15 (koebnerisin) subfamily: highly homologous but distinct in regulation and function | Q28286769 | ||
| S100A1: a multifaceted therapeutic target in cardiovascular disease | Q28288362 | ||
| The S100 protein family: history, function, and expression | Q28293937 | ||
| A link between inflammation and metastasis: serum amyloid A1 and A3 induce metastasis, and are targets of metastasis-inducing S100A4 | Q28306743 | ||
| Common interactions between S100A4 and S100A9 defined by a novel chemical probe | Q28487759 | ||
| The S100A8-serum amyloid A3-TLR4 paracrine cascade establishes a pre-metastatic phase | Q28507440 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| S100A4 regulates macrophage chemotaxis | Q30495765 | ||
| A biosensor of S100A4 metastasis factor activation: inhibitor screening and cellular activation dynamics | Q33312065 | ||
| S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation | Q33322536 | ||
| Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes | Q33329750 | ||
| Expression patterns of S100 proteins in melanocytes and melanocytic lesions | Q33466720 | ||
| Myeloid-derived suppressor cells in the development of lung cancer | Q33555717 | ||
| Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK | Q33556286 | ||
| S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer | Q33685170 | ||
| Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice | Q33721765 | ||
| Folding and binding cascades: shifts in energy landscapes | Q33723481 | ||
| Diversity of conformational states and changes within the EF-hand protein superfamily | Q33790634 | ||
| Differential role of psoriasin (S100A7) in estrogen receptor α positive and negative breast cancer cells occur through actin remodeling | Q33804642 | ||
| Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis | Q33822378 | ||
| The effect of pentamidine on melanoma ex vivo. | Q33835672 | ||
| Simultaneous inhibition of key growth pathways in melanoma cells and tumor regression by a designed bidentate constrained helical peptide | Q33934743 | ||
| Cysteine 81 is critical for the interaction of S100A4 and myosin-IIA | Q33958590 | ||
| The calcium-binding protein S100B down-regulates p53 and apoptosis in malignant melanoma | Q34094678 | ||
| Sumoylation and Nuclear Translocation of S100A4 Regulate IL-1β-mediated Production of Matrix Metalloproteinase-13 | Q34181448 | ||
| Phase II randomized, double-blind, placebo-controlled study of tasquinimod in men with minimally symptomatic metastatic castrate-resistant prostate cancer | Q34217642 | ||
| Psoriasin (S100A7) increases the expression of ROS and VEGF and acts through RAGE to promote endothelial cell proliferation | Q34242174 | ||
| Inhibition of metastasis in a castration resistant prostate cancer model by the quinoline-3-carboxamide tasquinimod (ABR-215050). | Q34250496 | ||
| Inhibiting S100B restores p53 levels in primary malignant melanoma cancer cells | Q34324710 | ||
| Molecular interface of S100A8 with cytochrome b558 and NADPH oxidase activation | Q34341915 | ||
| PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation. | Q34376145 | ||
| Covalent small molecule inhibitors of Ca(2+)-bound S100B. | Q34414451 | ||
| Intervening in β-catenin signaling by sulindac inhibits S100A4-dependent colon cancer metastasis | Q34551546 | ||
| Identification of small-molecule inhibitors of the human S100B-p53 interaction and evaluation of their activity in human melanoma cells. | Q34572489 | ||
| S100P is a novel interaction partner and regulator of IQGAP1 | Q34606213 | ||
| The induction of S100p expression by the Prostaglandin E2(PGE2)/EP4 receptor signaling pathway in colon cancer cells | Q34616607 | ||
| The role of conformational entropy in molecular recognition by calmodulin | Q34632794 | ||
| S100A8/A9 activate key genes and pathways in colon tumor progression | Q34802977 | ||
| Functional role of S100A14 genetic variants and their association with esophageal squamous cell carcinoma | Q34974664 | ||
| Structure of the S100A4/myosin-IIA complex | Q35047058 | ||
| S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma | Q35055025 | ||
| S100A4 accelerates tumorigenesis and invasion of human prostate cancer through the transcriptional regulation of matrix metalloproteinase 9 | Q35075493 | ||
| S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells | Q35210979 | ||
| VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization | Q35229115 | ||
| APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis | Q35484686 | ||
| Tumor-suppressive effects of psoriasin (S100A7) are mediated through the β-catenin/T cell factor 4 protein pathway in estrogen receptor-positive breast cancer cells | Q35639956 | ||
| Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models | Q35702968 | ||
| Profiling signaling polarity in chemotactic cells. | Q35850143 | ||
| S100 calcium binding proteins and ion channels | Q35911792 | ||
| Target binding to S100B reduces dynamic properties and increases Ca(2+)-binding affinity for wild type and EF-hand mutant proteins | Q36291452 | ||
| Design of Inhibitors for S100B. | Q36296626 | ||
| Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility | Q36320546 | ||
| Systemic shRNA mediated knock down of S100A4 in colorectal cancer xenografted mice reduces metastasis formation. | Q36339222 | ||
| Global identification of MLL2-targeted loci reveals MLL2's role in diverse signaling pathways | Q36378382 | ||
| Coupling S100A4 to Rhotekin alters Rho signaling output in breast cancer cells. | Q36476504 | ||
| A CXCL1 paracrine network links cancer chemoresistance and metastasis | Q36482032 | ||
| RAGE signaling sustains inflammation and promotes tumor development | Q36502858 | ||
| Cyclooxygenase-2 is involved in S100A2-mediated tumor suppression in squamous cell carcinoma. | Q40243783 | ||
| S100-mediated signal transduction in the nervous system and neurological diseases. | Q40371571 | ||
| The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer | Q40402282 | ||
| Interleukin-6 is a potent inducer of S100P, which is up-regulated in androgen-refractory and metastatic prostate cancer | Q40505958 | ||
| Identification and characterization of small molecule inhibitors of the calcium-dependent S100B-p53 tumor suppressor interaction. | Q40509580 | ||
| Histone deacetylase inhibitors such as sodium butyrate and trichostatin A induce apoptosis through an increase of the bcl-2-related protein Bad. | Q40743083 | ||
| Transfection of S100A4 produces metastatic variants of an orthotopic model of bladder cancer | Q40751670 | ||
| The metastasis-associated Mts1(S100A4) protein could act as an angiogenic factor | Q40787009 | ||
| Human S100A4 (p9Ka) induces the metastatic phenotype upon benign tumour cells | Q41018525 | ||
| Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma | Q41093031 | ||
| Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours | Q41158050 | ||
| Non-muscle myosin heavy chain as a possible target for protein encoded by metastasis-related mts-1 gene | Q41449150 | ||
| Induction of the metastatic phenotype by transfection of a benign rat mammary epithelial cell line with the gene for p9Ka, a rat calcium-binding protein, but not with the oncogene EJ-ras-1. | Q41562528 | ||
| Epigenetic regulation of S100 protein expression | Q41810264 | ||
| Therapeutic safety of high myocardial expression levels of the molecular inotrope S100A1 in a preclinical heart failure model | Q41890749 | ||
| S100A4 silencing blocks invasive ability of esophageal squamous cell carcinoma cells | Q42092162 | ||
| Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration | Q42149470 | ||
| S100A14 promotes the growth and metastasis of hepatocellular carcinoma | Q42253768 | ||
| Three-dimensional pharmacophore design and biochemical screening identifies substituted 1,2,4-triazoles as inhibitors of the annexin A2-S100A10 protein interaction. | Q42351969 | ||
| The Calcium-Dependent Interaction of S100B with Its Protein Targets | Q42431159 | ||
| The role of S100 genes in breast cancer progression | Q42481244 | ||
| Evolution of the S100 family of calcium sensor proteins | Q42681277 | ||
| The S100A4 Oncoprotein Promotes Prostate Tumorigenesis in a Transgenic Mouse Model: Regulating NFκB through the RAGE Receptor. | Q42969892 | ||
| Changes in S100A8 expression in UV-irradiated and aged human skin in vivo | Q43873330 | ||
| Interaction of S100 proteins with the antiallergic drugs, olopatadine, amlexanox, and cromolyn: identification of putative drug binding sites on S100A1 protein | Q43955145 | ||
| The gatekeeper effect of epithelial-mesenchymal transition regulates the frequency of breast cancer metastasis. | Q44480772 | ||
| Psoriasin (S100A7) expression is associated with poor outcome in estrogen receptor-negative invasive breast cancer | Q44509716 | ||
| The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer's disease mouse model | Q44710510 | ||
| S100A8 and S100A9-oxidant scavengers in inflammation. | Q44967617 | ||
| Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. | Q45254364 | ||
| The metastasis-promoting S100A4 protein confers neuroprotection in brain injury | Q45368362 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 96-109 | |
| P577 | publication date | 2015-02-01 | |
| P1433 | published in | Nature Reviews Cancer | Q641657 |
| P1476 | title | S100 proteins in cancer | |
| P478 | volume | 15 |
| Q92286707 | A Clinicopathological Analysis of S100A14 Expression in Colorectal Cancer |
| Q96128233 | A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis |
| Q93016458 | A Specific Blood Signature Reveals Higher Levels of S100A12: A Potential Bladder Cancer Diagnostic Biomarker Along With Urinary Engrailed-2 Protein Detection |
| Q90298989 | A multiomics analysis of S100 protein family in breast cancer |
| Q28069018 | Adapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in Melanoma |
| Q28551888 | An Interplay of S-Nitrosylation and Metal Ion Binding for Astrocytic S100B Protein |
| Q50335104 | Baden Prevention and Reduction of Incidence of Postoperative Delirium Trial (PRIDe): a phase IV multicenter, randomized, placebo-controlled, double-blind clinical trial of ketamine versus haloperidol for prevention of postoperative delirium. |
| Q93069475 | Biochemical pathways mediated by KLK6 protease in breast cancer |
| Q53423632 | Biomarkers of chondrosarcoma. |
| Q55177580 | C10orf99 contributes to the development of psoriasis by promoting the proliferation of keratinocytes. |
| Q38924971 | Calcium role in human carcinogenesis: a comprehensive analysis and critical review of literature. |
| Q47854911 | Cell-autonomous and non-autonomous functions of S100A4 in regulating stemness, mesenchymal transition, and metastasis. |
| Q52584341 | Characterization of increasing stages of invasiveness identifies stromal/cancer cell crosstalk in rat models of mesothelioma. |
| Q45964566 | Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. |
| Q52347068 | Chronic Inflammatory Microenvironment in Epidermodysplasia Verruciformis Skin Lesions: Role of the Synergism Between HPV8 E2 and C/EBPβ to Induce Pro-Inflammatory S100A8/A9 Proteins. |
| Q58614815 | Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study |
| Q89352748 | Circulating S100A8 and S100A9 protein levels in plasma of patients with acquired aplastic anemia and myelodysplastic syndromes |
| Q64114268 | Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer |
| Q55495092 | Clinical significance of calcium-binding protein S100A8 and S100A9 expression in non-small cell lung cancer. |
| Q92618864 | Clinicopathologic features of epithelioid sarcoma: report of seventeen cases and review of literature |
| Q59131874 | Colorectal cancer liver metastatic growth depends on PAD4-driven citrullination of the extracellular matrix |
| Q92192957 | Combinatorial Electrophoresis and Mass Spectrometry-Based Proteomics in Breast Milk for Breast Cancer Biomarker Discovery |
| Q88657525 | Comparative two-dimensional polyacrylamide gel electrophoresis (2D-PAGE) of human milk to identify dysregulated proteins in breast cancer |
| Q38943440 | Control of cell mechanics by RhoA and calcium fluxes during epithelial scattering |
| Q52311196 | Correlating Clinical Risk Factors and Histological Features in Ruptured and Unruptured Human Intracranial Aneurysms: The Swiss AneuX Study. |
| Q92382461 | Curcumin increases the sensitivity of K562/DOX cells to doxorubicin by targeting S100 calcium-binding protein A8 and P-glycoprotein |
| Q28067434 | Damage-associated molecular patterns in cancer: a double-edged sword |
| Q88814753 | Desorption Electrospray Ionization Mass Spectrometry Imaging of Proteins Directly from Biological Tissue Sections |
| Q36054847 | Difference in Membrane Repair Capacity Between Cancer Cell Lines and a Normal Cell Line |
| Q89741538 | Direct interaction of metastasis-inducing S100P protein with tubulin causes enhanced cell migration without changes in cell adhesion |
| Q59804232 | Discovering proteins for chemoprevention and chemotherapy by curcumin in liver fluke infection-induced bile duct cancer |
| Q37554595 | Distinct prognostic values of S100 mRNA expression in breast cancer |
| Q92419659 | Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy |
| Q51736289 | EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma. |
| Q98624989 | Effects of inducing apoptosis and inhibiting proliferation of siRNA on polyadenylate-binding protein-interacting protein 1 in tongue cell carcinoma |
| Q47319482 | Elevated S100A8 protein expression in breast cancer cells and breast tumor stroma is prognostic of poor disease outcome |
| Q48252165 | Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC). |
| Q93059360 | Establishment and Characterization of a New Triple Negative Breast Cancer Cell Line from an Iranian Breast Cancer Tissue |
| Q92668941 | Exosomes released upon mitochondrial ASncmtRNA knockdown reduce tumorigenic properties of malignant breast cancer cells |
| Q41072445 | Expression and clinical implication of S100A12 in gastric carcinoma |
| Q40671439 | Expression and clinical role of chemoresponse-associated genes in ovarian serous carcinoma |
| Q40189254 | Expression, Purification, and Antimicrobial Activity of S100A12. |
| Q36369093 | Ezrin interacts with S100A4 via both its N- and C-terminal domains. |
| Q48108646 | Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases |
| Q39133115 | Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases |
| Q36410591 | Functional profile of S100A4-deficient T cells |
| Q97518383 | Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing |
| Q38939435 | HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins |
| Q91825128 | Hepatic gene expression explains primary drug toxicity in bipolar disorder |
| Q30787185 | Human S100A10 plays a crucial role in the acquisition of the endometrial receptivity phenotype. |
| Q89930021 | Identification of Novel Prognosis and Prediction Markers in Advanced Prostate Cancer Tissues Based on Quantitative Proteomics |
| Q58084858 | Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq |
| Q92435902 | Increased S100A8 expression in bone marrow plasma by monocytic cells from acute myeloid leukemia patients |
| Q52723319 | Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells. |
| Q38771560 | Innate immune memory: Implications for host responses to damage-associated molecular patterns |
| Q90703634 | Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia |
| Q89865692 | Interaction of calcium binding protein S100A16 with myosin-9 promotes cytoskeleton reorganization in renal tubulointerstitial fibrosis |
| Q64062207 | Knockdown of TRAF3IP2 suppresses the expression of VEGFA and the proliferation of keratinocytes and vascular endothelial cells |
| Q38690062 | Kv10.1 K(+) channel: from physiology to cancer. |
| Q98178012 | Lipid and protein tumor markers for head and neck squamous cell carcinoma identified by imaging mass spectrometry |
| Q37058122 | Loss of Ezh2 cooperates with Jak2V617F in the development of myelofibrosis in a mouse model of myeloproliferative neoplasm |
| Q65950270 | MYH9: Structure, functions and role of non-muscle myosin IIA in human disease. |
| Q41512797 | Metastasis-inducing proteins are widely expressed in human brain metastases and associated with intracranial progression and radiation response |
| Q37636703 | Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma |
| Q98465934 | Molecular mechanisms and clinical management of cancer bone metastasis |
| Q39183513 | Molecular mechanisms of tumour invasion: regulation by calcium signals |
| Q39159735 | Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma. |
| Q61443131 | Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma |
| Q88956893 | Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology |
| Q51640635 | Multilevel Changes in Protein Dynamics upon Complex Formation of the Calcium-Loaded S100A4 with a Nonmuscle Myosin IIA Tail Fragment. |
| Q36169181 | Multiple Evolutionary Origins of Ubiquitous Cu2+ and Zn2+ Binding in the S100 Protein Family |
| Q57181491 | Multiple S100 protein isoforms and C-terminal phosphorylation contribute to the paralog-selective regulation of nonmuscle myosin 2 filaments |
| Q26799126 | Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment |
| Q89545561 | Myosin X is required for efficient melanoblast migration and melanoma initiation and metastasis |
| Q89879464 | Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer |
| Q37006985 | Novel protein-inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography |
| Q37642191 | Ongoing Response in BRAF V600E-Mutant Melanoma After Cessation of Intermittent Vemurafenib Therapy: A Case Report |
| Q90486716 | Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer |
| Q55475560 | Overexpression of S100A14 contributes to malignant progression and predicts poor prognosis of lung adenocarcinoma. |
| Q36524069 | Overexpression of S100A14 in human serous ovarian carcinoma |
| Q38699339 | Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs). |
| Q41194460 | Palbociclib induces activation of AMPK and inhibits hepatocellular carcinoma in a CDK4/6-independent manner |
| Q90290115 | Pathophysiology of atherothrombosis: Mechanisms of thrombus formation on disrupted atherosclerotic plaques |
| Q38743711 | Pre-metastatic niches: organ-specific homes for metastases. |
| Q60044321 | Prognostic values of S100 family members in ovarian cancer patients |
| Q38372053 | Proteome Characterization of Human Pancreatic Cyst Fluid from Intraductal Papillary Mucinous Neoplasm by LC/MS/MS. |
| Q36928906 | Quantitative Proteomics Analysis of Tissue Interstitial Fluid for Identification of Novel Serum Candidate Diagnostic Marker for Hepatocellular Carcinoma |
| Q99566088 | Quantitative proteomic analysis of urinary exosomes in kidney stone patients |
| Q38708023 | Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival |
| Q33899239 | Quantitative proteomics reveal the anti-tumour mechanism of the carbohydrate recognition domain of Galectin-3 in Hepatocellular carcinoma |
| Q89484239 | RAGE and Its Ligands: Molecular Interplay Between Glycation, Inflammation, and Hallmarks of Cancer-a Review |
| Q38964572 | RAGE: A novel target for breast cancer growth and metastasis |
| Q64111589 | Realizing the Clinical Potential of Immunogenic Cell Death in Cancer Chemotherapy and Radiotherapy |
| Q38700311 | Reduction in Migratory Phenotype in a Metastasized Breast Cancer Cell Line via Downregulation of S100A4 and GRM3. |
| Q58721652 | Regulation of S100A8 Stability by RNF5 in Intestinal Epithelial Cells Determines Intestinal Inflammation and Severity of Colitis |
| Q26776055 | Regulation of the Intestinal Barrier Function by Host Defense Peptides |
| Q55610234 | Regulation of von-Willebrand Factor Secretion from Endothelial Cells by the Annexin A2-S100A10 Complex. |
| Q38689543 | Retrospective Proteomic Screening of 100 Breast Cancer Tissues. |
| Q36909178 | Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9 |
| Q58576722 | S100 Proteins in Acute Myeloid Leukemia |
| Q58086680 | S100 proteins as therapeutic targets |
| Q92964700 | S100 proteins: An emerging cynosure in pregnancy & adverse reproductive outcome |
| Q39031292 | S100A1 and S100B: Calcium Sensors at the Cross-Roads of Multiple Chondrogenic Pathways |
| Q60947864 | S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer |
| Q96576801 | S100A14 suppresses metastasis of nasopharyngeal carcinoma by inhibition of NF-kB signaling through degradation of IRAK1 |
| Q55293322 | S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells. |
| Q47953375 | S100A4 Is a Biomarker and Regulator of Glioma Stem Cells That Is Critical for Mesenchymal Transition in Glioblastoma |
| Q64996301 | S100A4 May Be a Good Prognostic Marker and a Therapeutic Target for Colon Cancer. |
| Q92458745 | S100A4 alters metabolism and promotes invasion of lung cancer cells by up-regulating mitochondrial complex I protein NDUFS2 |
| Q57072975 | S100A4 as a Target of the E3-Ligase Asb2β and Its Effect on Engineered Heart Tissue |
| Q37376360 | S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide |
| Q26743403 | S100A4 in Cancer Metastasis: Wnt Signaling-Driven Interventions for Metastasis Restriction |
| Q42700673 | S100A4 in cancer progression and metastasis: A systematic review |
| Q64256146 | S100A4 inhibits cell proliferation by interfering with the S100A1-RAGE V domain |
| Q47251142 | S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms |
| Q90472393 | S100A4 suppresses cancer stem cell proliferation via interaction with the IKK/NF-κB signaling pathway |
| Q54120638 | S100A6 promotes the proliferation and migration of cervical cancer cells via the PI3K/Akt signaling pathway. |
| Q39247295 | S100A6 protein: functional roles |
| Q47927472 | S100A7: from mechanism to cancer therapy |
| Q99237974 | S100A8 and S100A9 Promote Apoptosis of Chronic Eosinophilic Leukemia Cells |
| Q36287418 | S100A9 expressed in ER(-)PgR(-) breast cancers induces inflammatory cytokines and is associated with an impaired overall survival |
| Q57777508 | S100A9-Driven Amyloid-Neuroinflammatory Cascade in Traumatic Brain Injury as a Precursor State for Alzheimer's Disease |
| Q50000872 | S100B as an antagonist to block the interaction between S100A1 and the RAGE V domain. |
| Q38717429 | S100B impairs glycolysis via enhanced poly(ADP-ribosyl)ation of glyceraldehyde-3-phosphate dehydrogenase in rodent muscle cells |
| Q92283914 | S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis |
| Q36151388 | S100β-Positive Cells of Mesenchymal Origin Reside in the Anterior Lobe of the Embryonic Pituitary Gland |
| Q58749358 | STIM1 and STIM2 Mediate Cancer-Induced Inflammation in T Cell Acute Lymphoblastic Leukemia |
| Q99711498 | Schistosoma japonicum SjE16.7 Protein Promotes Tumor Development via the Receptor for Advanced Glycation End Products (RAGE) |
| Q37314018 | Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma |
| Q92636095 | Significance of 5-S-Cysteinyldopa as a Marker for Melanoma |
| Q58712956 | Single-cell heterogeneity in Sézary syndrome |
| Q97595758 | Single-cell transcriptomics reveals regulators underlying immune cell diversity and immune subtypes associated with prognosis in nasopharyngeal carcinoma |
| Q35884035 | Small Molecule Inhibitors of Ca(2+)-S100B Reveal Two Protein Conformations. |
| Q51201229 | Solving the crystal structure of human calcium-free S100Z: the siege and conquer of one of the last S100 family strongholds. |
| Q36419214 | Structural Basis of Ribosomal S6 Kinase 1 (RSK1) Inhibition by S100B Protein: MODULATION OF THE EXTRACELLULAR SIGNAL-REGULATED KINASE (ERK) SIGNALING CASCADE IN A CALCIUM-DEPENDENT WAY. |
| Q49316629 | Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice |
| Q36783309 | Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex |
| Q91620971 | TBKBP1 and TBK1 form a growth factor signalling axis mediating immunosuppression and tumourigenesis |
| Q38595544 | Targeting danger-associated molecular patterns after myocardial infarction |
| Q39178065 | The Microenvironmental Landscape of Brain Tumors |
| Q39061503 | The Multiple Roles of Exosomes in Metastasis |
| Q34463903 | The calcium-sensing receptor: A promising target for prevention of colorectal cancer. |
| Q47682759 | The importance of calprotectin levels in obstructive sleep apnea syndrome severity |
| Q26749135 | The life and works of S100P - from conception to cancer |
| Q38598852 | The role of S100 proteins and their receptor RAGE in pancreatic cancer |
| Q41396244 | The tumor microenvironment and inflammatory breast cancer |
| Q37179521 | The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis |
| Q48181383 | Therapeutic potential of targeting S100A11 in malignant pleural mesothelioma. |
| Q30924798 | Toward predicting metastatic progression of melanoma based on gene expression data |
| Q37619731 | Transcriptome-wide identification of mRNAs and lincRNAs associated with trastuzumab-resistance in HER2-positive breast cancer |
| Q61797276 | Transcriptomic and ChIP-sequence interrogation of EGFR signaling in HER2+ breast cancer cells reveals a dynamic chromatin landscape and S100 genes as targets |
| Q93040540 | Tumor-associated factors are enriched in lymphatic exudate compared to plasma in metastatic melanoma patients |
| Q98164431 | Unveiling functional heterogeneity in breast cancer multicellular tumor spheroids through single-cell RNA-seq |
| Q38909800 | Why Calcium? How Calcium Became the Best Communicator |
| Q48234052 | X-ray crystal structure of human calcium-bound S100A1. |
| Q92256343 | ZEB1 and IL-6/11-STAT3 signalling cooperate to define invasive potential of pancreatic cancer cells via differential regulation of the expression of S100 proteins |
Search more.